Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011, Article ID 190230, 6 pages
http://dx.doi.org/10.4061/2011/190230
Review Article

The Role of Ultrafiltration in Patients with Decompensated Heart Failure

Division of Cardiovascular Medicine, University of Virginia Health System, P.O. Box 800158, Charlottesville, VA 22908, USA

Received 15 August 2010; Accepted 1 September 2010

Academic Editor: Mitchell H. Rosner

Copyright © 2011 Sandeep A. Kamath. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “Heart disease and stroke statistics—2010 update: a report from the american heart association,” Circulation, vol. 121, no. 7, pp. e46–e215, 2010. View at Publisher · View at Google Scholar
  2. A. Ahmed, R. M. Allman, G. C. Fonarow et al., “Incident f hospitalization and subsequent mortality in chronic Heart Failure: a propensity-matched study,” Journal of Cardiac Failure, vol. 14, no. 3, pp. 211–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. K. Mulvey, Y. Wang, Z. Lin et al., “Mortality and readmission for patients with Heart Failure among U.S. News & World Report's top heart hospitals,” Circulation: Cardiovascular Quality and Outcomes, vol. 2, no. 6, pp. 558–565, 2009. View at Publisher · View at Google Scholar
  4. K. F. Adams Jr., G. C. Fonarow, C. L. Emerman et al., “Characteristics and outcomes of patients hospitalized for Heart Failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE),” American Heart Journal, vol. 149, no. 2, pp. 209–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Drazner, J. E. Rame, L. W. Stevenson, and D. L. Dries, “Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with Heart Failure,” The New England Journal of Medicine, vol. 345, no. 8, pp. 574–581, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Brater, “Diuretic therapy,” The New England Journal of Medicine, vol. 339, no. 6, pp. 387–395, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lindenfeld, N. M. Albert, J. P. Boehmer et al., “HFSA 2010 comprehensive Heart Failure practice guideline,” Journal of Cardiac Failure, vol. 16, no. 6, pp. e1–e149, 2010. View at Google Scholar
  8. M. Sarraf, A. Masoumi, and R. W. Schrier, “Cardiorenal syndrome in acute decompensated Heart Failure,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 12, pp. 2013–2026, 2009. View at Publisher · View at Google Scholar
  9. W. Mullens, Z. Abrahams, G. S. Francis et al., “Importance of venous congestion for worsening of renal function in advanced decompensated Heart Failure,” Journal of the American College of Cardiology, vol. 53, no. 7, pp. 589–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. A. Cooper, D. L. Dries, C. E. Davis, Y. L. Shen, and M. J. Domanski, “Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction,” Circulation, vol. 100, no. 12, pp. 1311–1315, 1999. View at Google Scholar · View at Scopus
  11. A. Ahmed, A. Husain, T. E. Love et al., “Heart Failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods,” European Heart Journal, vol. 27, no. 12, pp. 1431–1439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Domanski, X. Tian, M. Haigney, and B. Pitt, “Diuretic use, progressive Heart Failure, and death in patients in the DIG study,” Journal of Cardiac Failure, vol. 12, no. 5, pp. 327–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Eshaghian, T. B. Horwich, and G. C. Fonarow, “Relation of loop diuretic dose to mortality in advanced Heart Failure,” American Journal of Cardiology, vol. 97, no. 12, pp. 1759–1764, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Hasselblad, W. G. Stough, M. R. Shah et al., “Relation between dose of loop diuretics and outcomes in a Heart Failure population: results of the ESCAPE Trial,” European Journal of Heart Failure, vol. 9, no. 10, pp. 1064–1069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. W. F. Peacock, M. R. Costanzo, T. De Marco et al., “Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated Heart Failure: insights from the ADHERE registry,” Cardiology, vol. 113, no. 1, pp. 12–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Cotter, E. Metzkor, E. Kaluski et al., “Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema,” The Lancet, vol. 351, no. 9100, pp. 389–393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Cotter, J. Weissgarten, E. Metzkor et al., “Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive Heart Failure,” Clinical Pharmacology and Therapeutics, vol. 62, no. 2, pp. 187–193, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Bayliss, M. Norell, and R. Canepa-Anson, “Untreated Heart Failure: clinical and neuroendocrine effects of introducing diuretics,” British Heart Journal, vol. 57, no. 1, pp. 17–22, 1987. View at Google Scholar · View at Scopus
  19. G. S. Francis, C. Benedict, D. E. Johnstone et al., “Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive Heart Failure. A substudy of the studies of left ventricular dysfunction (SOLVD),” Circulation, vol. 82, no. 5, pp. 1724–1729, 1990. View at Google Scholar · View at Scopus
  20. G. S. Francis, R. M. Siegel, and S. R. Goldsmith, “Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive Heart Failure. Activation of the neurohumoral axis,” Annals of Internal Medicine, vol. 103, no. 1, pp. 1–6, 1985. View at Google Scholar · View at Scopus
  21. J. M. McCurley, S. U. Hanlon, S.-K. Wei, E. F. Wedam, M. Michalski, and M. C. Haigney, “Furosemide and the progression of left ventricular dysfunction in experimental Heart Failure,” Journal of the American College of Cardiology, vol. 44, no. 6, pp. 1301–1307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. R. Nissenson, J. S. Berns, and E. V. Lerma, Current Diagnosis & Treatment. Nephrology & Hypertension, McGraw–Hill, New York, NY, USA, 2009.
  23. G. Marenzi, G. Lauri, M. Grazi, E. Assanelli, J. Campodonico, and P. Agostoni, “Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive Heart Failure,” Journal of the American College of Cardiology, vol. 38, no. 4, pp. 963–968, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Marenzi, S. Grazi, F. Giraldi et al., “Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive Heart Failure: effects of extracorporeal ultrafiltration,” American Journal of Medicine, vol. 94, no. 1, pp. 49–56, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Rimondini, C. M. Cipolla, P. D. Bella et al., “Hemofiltration as short-term treatment for refractory congestive heart failure,” American Journal of Medicine, vol. 83, no. 1, pp. 43–48, 1987. View at Google Scholar
  26. I. A. Simpson, A. P. Rae, and K. Simpson, “Ultrafiltration in the management of refractory congestive Heart Failure,” British Heart Journal, vol. 55, no. 4, pp. 344–347, 1986. View at Google Scholar · View at Scopus
  27. M. R. Costanzo, M. Saltzberg, J. O'Sullivan, and P. Sobotka, “Early ultrafiltration in patients with decompensated Heart Failure and diuretic resistance,” Journal of the American College of Cardiology, vol. 46, no. 11, pp. 2047–2051, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. A. Bart, A. Boyle, A. J. Bank et al., “Ultrafiltration versus usual care for hospitalized patients with Heart Failure: the relief for acutely fluid-overloaded patients with decompensated congestive Heart Failure (RAPID-CHF) trial,” Journal of the American College of Cardiology, vol. 46, no. 11, pp. 2043–2046, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. R. Costanzo, M. E. Guglin, M. T. Saltzberg et al., “Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure,” Journal of the American College of Cardiology, vol. 49, no. 6, pp. 675–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Costanzo, M. T. Saltzberg, M. Jessup, J. R. Teerlink, and P. A. Sobotka, “Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated Heart Failure: results from UNLOAD,” Journal of Cardiac Failure, vol. 16, no. 4, pp. 277–284, 2010. View at Publisher · View at Google Scholar
  31. K. V. Liang, A. R. Hiniker, A. W. Williams, B. L. Karon, E. L. Greene, and M. M. Redfield, “Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory Heart Failure: initial clinical experience in a single center,” Journal of Cardiac Failure, vol. 12, no. 9, pp. 707–714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Bradley, W. C. Levy, and D. L. Veenstra, “Cost-consequences of ultrafiltration for Acute Heart Failure: a decision model analysis,” Circulation, vol. 2, no. 6, pp. 566–573, 2009. View at Publisher · View at Google Scholar
  33. A. Kazory, A. A. Ejaz, and E. A. Ross, “Ultrafiltration for Heart Failure: how fast should we move?” American Heart Journal, vol. 157, no. 2, pp. 205–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Ross and A. Kazory, “Overcoming financial constraints of ultrafiltration for Heart Failure,” American Journal of Cardiology, vol. 105, no. 10, pp. 1504–1505, 2010. View at Publisher · View at Google Scholar
  35. A. Kazory and E. A. Ross, “Contemporary trends in the pharmacological and extracorporeal management of Heart Failure: a nephrologic perspective,” Circulation, vol. 117, no. 7, pp. 975–983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. A. Bart, “Treatment of congestion in congestive Heart Failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated Heart Failure,” Circulation: Heart Failure, vol. 2, no. 5, pp. 499–504, 2009. View at Publisher · View at Google Scholar · View at Scopus